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DNA Damage Foci at Dysfunctional Telomeres
nized by the DNA damage machinery. Here, we showHiroyuki Takai, Agata Smogorzewska,
and Titia de Lange* that experimentally uncapped telomeres invoke the ear-
liest known cellular response to DNA damage, the for-Laboratory for Cell Biology and Genetics
The Rockefeller University mation of foci containing DNA damage response factors.
In this study, telomere uncapping is achieved throughNew York, New York 10021
inactivation of the duplex TTAGGG repeat binding factor
TRF2 [5, 10, 11], which is essential for telomere protec-
tion. TRF2 is inhibited by using RNAi or a dominant-nega-Summary
tive TRF2 allele (TRF2BM), which prevents accumulation
of the endogenous TRF2 on telomeres [12]. Although theWe report cytologic and genetic data indicating that
duplex telomeric DNA remains intact when TRF2 is in-telomere dysfunction induces a DNA damage re-
hibited, much of the single-stranded 3 overhang disap-sponse in mammalian cells. Dysfunctional, uncapped
pears and telomeres undergo nonhomologous end join-telomeres, created through inhibition of TRF2, became
ing [12, 13]. TRF2BM induces apoptosis in lymphocytesassociated with DNA damage response factors, such
[6] and senescence in primary fibroblasts [14].as 53BP1, -H2AX, Rad17, ATM, and Mre11. We refer
If uncapped telomeres resemble damaged DNA, theyto the domain of telomere-associated DNA damage fac-
might become associated with DNA damage responsetors as a Telomere Dysfunction-Induced Focus (TIF). The
factors, such as 53BP1, Mre11, and phosphorylatedaccumulation of 53BP1 on uncapped telomeres was
forms of Rad17, H2AX, and ATM [15–20]. To test this,reduced in the presence of the PI3 kinase inhibitors
hTERT-immortalized BJ human fibroblasts were in-caffeine and wortmannin, which affect ATM, ATR, and
fected with a TRF2BM adenovirus [6]. As a control, cellsDNA-PK. By contrast, Mre11 TIFs were resistant to
were infected in parallel with a -galactosidase virus.caffeine, consistent with previous findings on the
Within 2 days of infection, the expression of TRF2BMMre11 response to ionizing radiation. A-T cells had a
induced numerous 53BP1 foci, and dual staining indi-diminished 53BP1 TIF response, indicating that the
cated that many of the foci colocalized with TRF1 andATM kinase is a major transducer of this pathway.
therefore represented telomeric loci (Figures 1A and 1B).However, in the absence of ATM, TRF2 inhibition still
Scoring of 75 nuclei showed a mean of 11.0 (SD  11.1;induced TIFs and senescence, pointing to a second
range 0–39) 53BP1 foci per nucleus (examining one focalATM-independent pathway. We conclude that the cel-
plane per nucleus), and of these, 60% colocalized withlular response to telomere dysfunction is governed by
TRF1. In contrast, 53BP1 foci induced by IR did notproteins that also control the DNA damage response.
colocalize with TRF1 (Figure 1A). Although the meanTIFs represent a new tool for evaluating telomere sta-
number of IR-induced 53BP1 foci was 30 per cell (SD tus in normal and malignant cells suspected of harbor-
7.6, n  25), only 1 or 2 of these foci colocalized withing dysfunctional telomeres. Furthermore, induction
TRF1. Thus, the localization of 53BP1 to telomeres wasof TIFs through TRF2 inhibition provides an opportu-
specifically induced by inhibition of TRF2.nity to study the DNA damage response within the
Images obtained by using a deconvolution micro-context of well-defined, physically marked lesions.
scope further confirmed the colocalization of 53BP1
with TRF1 and showed that the 53BP1 domain often
Results and Discussion extended considerably beyond the region of TRF1 stain-
ing (Figure 1B). This suggested that a large subtelomeric
Telomere dysfunction has been implicated in tumorigen- region became associated with 53BP1. The same effect
esis and aging (reviewed in [1–4]), yet little is known was observed when the fluorophores were switched
about the mechanisms by which mammalian cells per- (TRF1 detected with FITC and 53BP1 detected with
ceive and respond to the loss of telomere function. Telo- TRITC; data not shown). Therefore, we conclude that
mere uncapping occurs when cells have critically short- the 53BP1 domain is larger than the telomeric chromatin
ened telomeres or when telomere-protective factors are domain, as defined by the presence of TRF1.
impaired (reviewed in [5]). Under either circumstance, We refer to the 53BP1 foci at uncapped telomeres as
loss of telomere function can induce cell cycle arrest, Telomere Dysfunction-Induced Foci, or TIFs. TIFs are
senescence, apoptosis, and chromosome end fusions, defined as foci of DNA damage response factors that
outcomes that are consistent with the activation of a coincide with TRF1 signals. Although other DNA damage
DNA damage response. Supporting the view that telo- response factors also localize to telomeres (see below),
mere uncapping leads to a DNA damage response, loss TIFs are most easily detected with 53BP1 antibodies.
of telomere protection by TRF2 results in ATM- and We quantified the TIF response by examining the colo-
p53-dependent apoptosis, [6] and telomere shortening calization of 53BP1 and TRF1 in 25 nuclei (single focal
activates p53 in a variety of human and mouse cell types plane for each nucleus). Cells were considered TIF posi-
[7–9]. While suggestive, none of these findings provide tive if they contained four or more 53BP1 foci that colo-
direct evidence that dysfunctional telomeres are recog- calized with TRF1. Most of the TIF-positive cells con-
tained more than four 53BP1 foci at telomeres (mean
12.6, SD 7.4, n 38). While the fraction of TIF-positive*Correspondence: delange@mail.rockefeller.edu
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Figure 1. Binding of 53BP1 to Uncapped Telomeres
(A) TRF2BM, but not IR, induced telomeric localization of 53BP1. hTERT-BJ cells were infected with the indicated adenoviruses (control:
-galactosidase virus), were fixed 48–52 hr postinfection, and were processed for 53BP1 (green) and TRF1 (red) IF. DNA was stained (DAPI,
blue) in the merged images. IR: 2 Gy treatment, followed by IF after 1 hr.
(B) DeltaVision images. Infection and IF are as described in (A). The left images show a single nucleus. The enlarged images show additional
53BP1 foci at telomeres from this and other nuclei.
(C) TIF index (percentage of TIF-positive cells) of TRF2BM-expressing () and vector control () hTERT-BJ cells. Cells with four or more
53BP1 foci colocalizing with TRF1 were scored as TIF positive (n  75; SDs from three independent experiments). The multiplicity of infection
(m.o.i.) is as indicated.
(D) An immunoblot of a TRF2 knockdown with TRF2 siRNA. Whole-cell lysates of HeLaII cells harvested 48 hr after siRNA transfection with
the indicated siRNAs.
(E) HeLa1.2.11 cells transfected with TRF2 siRNA (#4), processed 72 after the first transfection for TRF2 or 53BP1 IF.
(F) Induction of TIFs with TRF2 siRNA. HeLaII cells were fixed and processed for 53BP1 and TRF1 IF 48 hr after the first transfection of siRNA
(TRF2 siRNA #2). The TIF index (n  25, from one experiment) is as in (C).
cells is negligible in control cultures, 30%–60% of the [21]. However, these foci rarely colocalize with TRF1
and do not affect the outcome of the TRF2 siRNA experi-cells infected with the TRF2BM adenovirus were TIF
positive (Figure 1C and see below). ments. Two independent TRF2 siRNAs (#2 and #4) re-
duced the expression of TRF2 considerably, as detectedInduction of 53BP1 foci at telomeres was also ob-
served after TRF2 inhibition with RNAi in HeLa cells by Western blotting and IF with two different HeLa cell
lines (Figures 1D and 1E). Cells with reduced TRF2 levels(Figures 1D and 1E). Some HeLa subclones have a con-
siderable basal level of 53BP1 foci in the absence of developed 53BP1 foci (Figure 1E) and showed a signifi-
cant increase in the fraction of TIF-positive cells as com-TRF2 inhibition (data not shown); this same phenome-
non has been described for several other tumor cell lines pared to cells treated with a control siRNA to GFP (Figure
DNA Damage Response at Telomeres
1551
Figure 2. Accumulation of Mre11 and Phosphorylated ATM, H2AX, and Rad17 on Uncapped Telomeres
hTERT-BJ cells were infected as in Figure 1A and were processed for IF by using antibodies to TRF1 (red) and Mre11, Ser 1981-phosphorylated
ATM, -H2AX, or Ser 645-phosphorylated Rad17 (green). Enlarged views of the merged images are shown to the right. DNA was stained by
DAPI (blue).
1F). These data corroborate the idea that the binding In addition to 53BP1, TIFs contained other well-estab-
lished DNA damage response factors, such as the Mre11of DNA damage response factors to telomeres in cells
expressing the dominant-negative allele of TRF2 is due complex, ATM, H2AX, and Rad17 (Figure 2) [15–19]. In
control cells, the Mre11 complex showed the previouslyto diminished TRF2 function.
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Figure 3. Progression through Mitosis Is Not Required for TIF Formation
(A) The experimental time line. Contact-inhibited hTERT-BJ cells were infected with adenovirus (100 pfu/cell) and were replated at low density.
Media containing 1 mM HU was added after 12 hr, resulting in G1/S arrest. Cells were fixed and processed for TIF analysis or stained with
S phase (PCNA) or M phase (Ser 10-phosphorylated histone H3) markers at 3, 6, and 12 hr after release from HU.
(B) S phase index at the indicated time points as determined by PCNA staining in mock-infected cells, TRF2 (full length)-infected cells, and
cells infected with TRF2BM (indicated by BM).
(C) The mitotic index at the indicated time points as determined by staining for phospho H3. Cell populations and time points are as in (B).
(D) The TIF index of cells infected with full-length TRF2 virus () or TRF2BM virus () at the indicated time points after release from HU.
noted IF pattern with most of the signal localizing to (for instance, see Figure 1B). Therefore, TIF-positive cells
are most likely to occur in late S phase or in G2 phase.PML bodies [17]. A small amount of Mre11 has been
shown to localize at telomeres [22], but this fraction is In some cases, both sister telomeres are associated
with 53BP1 (see enlarged inserts; Figure 1B). However,not detectable under the conditions used here. After
introduction of TRF2BM, many of the cells showed in other cases, only one of the two sister telomeres
contained detectable 53BP1, suggesting that telomereprominent Mre11 signals at telomeric sites (Figure 2).
Furthermore, phosphorylated histone H2AX (-H2AX), uncapping occurred during or after DNA replication. Per-
haps DNA replication contributes to the formation oractivated ATM phosphorylated on Ser 1981, and Rad17
phosphorylated on Ser 645 formed foci at telomeres sensing of the uncapped state at telomeres. It is also
possible that the inhibition of TRF2 with the dominant-after inhibition of TRF2 (Figure 2). As was noted for
53BP1, the Mre11, ATM, -H2AX, and Rad17 domains negative allele is enhanced during S phase.
We determined whether the TIF response dependedoften extended beyond the area of TRF1 staining. These
findings confirm and extend the previous inference that on signal transduction by PI3 kinases, such as ATM and
ATR [24]. Treating cells with the PI3 kinase inhibitors-H2AX occupies a very large region surrounding the
site of damage [23]. TRF2BM-mediated telomere un- caffeine and wortmannin resulted in a significant reduc-
tion in the accumulation of 53BP1 at telomeres incapping is known to leave the double-stranded telo-
meric DNA intact and results in a reduction of the TRF2BM-infected cells (Figures 4A and 4B). Caffeine
consistently reduced the percentage of TIF-positiveTTAGGG repeat overhang that normally protrudes 50–
200 nt 3 [12]. We infer from this knowledge that the cells by 3- to 5-fold (Figure 4B). Interestingly, the TIFs
were strongly reduced even after 1 hr of caffeine treat-binding of Mre11, ATM, H2AX, 53BP1 and Rad17 to
uncapped telomeres takes place at sites that do not ment. The most likely explanation is that TIFs require
ongoing signaling for their persistence. In contrast tocontain extensive regions of single-stranded DNA.
Using synchronized cultures, we found that cells be- the effect of caffeine on 53BP1, the binding of the Mre11
complex to telomeric sites was not affected by caffeinecame TIF positive in the first S phase or G2 phase after
infection with the TRF2BM adenovirus (Figure 3). This (Figure 4C). This finding is consistent with a previous
report documenting the formation of DNA damage re-indicated that progression through mitosis is not re-
quired for the TIF response. TIF-positive cells were rare sponse foci by the Mre11 complex in the presence of
caffeine [25]. The caffeine-resistant binding of the Mre11before the onset of DNA replication (data not shown) and
were primarily observed after cells had begun S phase complex to uncapped telomeres further bolsters the
view that this complex can act as a sensor of DNA(Figures 3B–3D). These findings suggest that DNA repli-
cation promotes TIF formation. Consistent with this, damage [18] and corroborates the idea that uncapped
telomeres resemble DNA lesions.many of the telomeres in TIF-positive cells appeared as
double dots, indicating that they have been duplicated In order to address the role of the ATM kinase in the
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Figure 4. Telomeric Binding of 53BP1, but Not Mre11, Is Affected by PI3-Kinase Inhibitors and ATM Status
(A) Inhibition of 53BP1 TIF formation by caffeine and wortmannin. TRF2BM-expressing hTERT-BJ cells were treated with 10 mM caffeine or
50 M wortmannin for 4 hr before fixation.
(B) The TIF index determined by using 53BP1 of hTERT-BJ cells treated with caffeine as in (A) at the indicated time points.
(C) The TIF index determined by using Mre11 of hTERT-BJ cells treated with caffeine as in (A) at the indicated time points.
(D) Reduced induction of TIFs in ATM-defective A-T fibroblasts. Asynchronously grown A-T fibroblasts (AG04405 and AG02496), or normal
human IMR90 fibroblasts, were infected with TRF2BM-expressing adenovirus or control adenovirus, fixed 48–52 hr after infection, and
processed for TIF analysis by 53BP1/TRF1 IF.
binding of 53BP1 to telomeres more directly, we tested empty retroviral vector [13]. TRF2BM induced a growth
arrest in all three A-T fibroblast strains, and the extentwhether TRF2 inhibition could induce TIF-positive cells
in fibroblasts derived from ataxia telangiectasia (A-T) and kinetics of this arrest was similar to that of A-T
heterozygous and wild-type fibroblasts (Figure 5B; [13]).patients, which are deficient in this kinase (reviewed in
[24]). The absence of the ATM kinase was verified by Furthermore, the cells expressed SA--galactosidase,
acquired a senescent morphology, and had increasedWestern blotting (see below). The TIF response in two
A-T cell strains was diminished compared to ATM-profi- levels of p21 and p16 (Figures 5C and 5D). Therefore,
we conclude that absence of the ATM kinase is notcient cells (Figure 4D). These data indicate that the ATM
kinase is a main transducer of the telomere damage sufficient to abrogate telomere-directed senescence.
This is consistent with the observation that replicativesignal. However, since A-T-deficient cells have a resid-
ual level of TIF formation, other signal transducers con- senescence of A-T cells can be bypassed by telomerase
[26, 27].tribute as well.
At the cellular level, the outcome of TRF2 inhibition The binding of 53BP1, Mre11, and the phosphorylated
forms of ATM, H2AX, and Rad17 to uncapped telomeresis either apoptosis or senescence. The apoptotic response
is attenuated in A-T cells [6], and this attenuation is indicates that cells perceive unprotected chromosome
ends as sites of DNA damage. The fact that TIFs areconsistent with the ATM kinase being involved in the
telomere damage signaling pathway. In order to exam- suppressed by caffeine and wortmannin and are dimin-
ished in A-T cells is consistent with an ATM-dependentine the role of the ATM kinase in the senescence re-
sponse, TRF2BM was introduced by retroviral infection response to dysfunctional telomeres. However, since
A-T cells show a residual level of TIF formation andinto three ATM-deficient A-T fibroblast strains; an ATM-
proficient heterozygous parental cell strain was used as undergo telomere-directed senescence, ATM-indepen-
dent pathways can be activated. Additional transducersa control (Figure 5A). The cell cycle arrest response to
TRF2BM was documented by measuring BrdU incorpo- of the telomere damage signal might be ATR or DNA-
PKcs. Activation of ATR kinase is thought to require theration in comparison to control cultures infected with the
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Figure 5. TRF2BM-Induced Senescence in A-T Fibroblasts
(A) A Western blot confirming the presence or absence of ATM in primary fibroblasts from A-T patients (AG04405, AG02496, AG03058A), the
heterozygous mother (AG03057) of one of the affected donors (AG03058A), and normal human primary fibroblasts (IMR90).
(B) Changes in BrdU incorporation in TRF2BM-expressing A-T cells. S phase cells were identified at the indicated time points based on BrdU
incorporation for 5 hr. Changes in BrdU incorporation are represented as the fraction of BrdU-positive cells in TRF2BM-expressing cells
divided by the fraction of BrdU-positive cells in vector control cells. This ratio is set at 100% for day 0.
(C) TRF2BM expression induces SA--gal activity and senescent morphology in AG02496 A-T cells. Photographs of IMR90 cells and AG02496
cells infected with TRF2BM-expressing retrovirus or control virus processed for SA--gal assay at the indicated time points are shown.
(D) Induction of p21 and p16 by TRF2BM. An immunoblot with cell lysates from retrovirally infected cells (viruses, time points, proteins, and
cells are as indicated).
binding of RPA to single-stranded DNA [28]. As dysfunc- viewed in [1, 33]) might reveal instances of telomere
dysfunction in vivo. Additionally, TIFs will be a valuabletional human telomeres do not generate extensive single-
stranded regions [12, 29], they may activate ATR relatively indicator of telomere status in cells deficient for telo-
mere-protective factors that have no overt telomere fu-poorly. This could explain why ATM is a main telomere
signal transducer in human cells, whereas in yeast, where sion phenotype. Finally, TIFs could reveal telomere dys-
function during various steps of human tumorigenesis.uncapped telomeres are rendered single stranded [30],
the ATR ortholog Mec1 plays this role [31]. Demonstration of uncapped telomeres in human cancer
may allow for direct testing of the proposal that telomereTIFs are novel markers for telomere dysfunction. Hith-
erto, the absence of telomere protection could only be dysfunction drives genome instability during tumorigen-
esis (reviewed in [2, 34]).deduced from end-to-end chromosome fusions and
their associated anaphase bridges. Such assays have The DNA damage response in mammalian cells has
been studied by using a variety of nonphysiologicallimitations since they require progression into mitosis,
despite telomere dysfunction. Furthermore, the forma- treatments, including ionizing radiation, radiomimetic
drugs, UV light, and laser treatment. Acute telomeretion of end-to-end chromosome fusions depends on the
removal of the 3 telomeric overhang and processing of uncapping with TRF2 is yet another means of inducing
DNA damage. The advantage of this method is that thethe ends by nonhomologous end joining. In so far as
the TIF assay primarily relies on ATM proficiency and the site of the lesion can be easily recognized by using
telomeric markers and that the exact DNA structure ofexpression of one of several DNA damage response
proteins (e.g., 53PBP1), it is a more versatile index of uncapped telomeres can be determined.
telomere dysfunction. Indeed, the TIF assay should dis-
Experimental Procedurestinguish between senescence in response to telomere
shortening (replicative senescence) or senescence due
Cell strains, cell culture procedures, viral gene delivery, immunoblot-to culture conditions (stasis or culture shock) (reviewed
ting, and IF techniques have been described previously [6, 13, 14,
in [3, 32]). Detection of TIFs in tissues of donors sus- 35, 36]. Experimental details and sources of antibodies are given in
pected of telomere abnormalities (such as dyskeratosis the Supplemental Data available with this article online.
For TRF2 RNAi, double-stranded siRNA were designed to targetcongenita, RecQ helicase syndromes, and aging) (re-
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